Loading…

SVSBI: sequence-based virtual screening of biomolecular interactions

Virtual screening (VS) is a critical technique in understanding biomolecular interactions, particularly in drug design and discovery. However, the accuracy of current VS models heavily relies on three-dimensional (3D) structures obtained through molecular docking, which is often unreliable due to th...

Full description

Saved in:
Bibliographic Details
Published in:Communications biology 2023-05, Vol.6 (1), p.536-12, Article 536
Main Authors: Shen, Li, Feng, Hongsong, Qiu, Yuchi, Wei, Guo-Wei
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Virtual screening (VS) is a critical technique in understanding biomolecular interactions, particularly in drug design and discovery. However, the accuracy of current VS models heavily relies on three-dimensional (3D) structures obtained through molecular docking, which is often unreliable due to the low accuracy. To address this issue, we introduce a sequence-based virtual screening (SVS) as another generation of VS models that utilize advanced natural language processing (NLP) algorithms and optimized deep K -embedding strategies to encode biomolecular interactions without relying on 3D structure-based docking. We demonstrate that SVS outperforms state-of-the-art performance for four regression datasets involving protein-ligand binding, protein-protein, protein-nucleic acid binding, and ligand inhibition of protein-protein interactions and five classification datasets for protein-protein interactions in five biological species. SVS has the potential to transform current practices in drug discovery and protein engineering. A sequence-based virtual screening method uses natural language processing algorithms and optimized deep K -embedding strategies to encode biomolecular interactions without relying on 3D structure-based docking.
ISSN:2399-3642
2399-3642
DOI:10.1038/s42003-023-04866-3